| AQP5 enriches for stem cells and cancer origins in the distal stomach SH Tan, Y Swathi, S Tan, J Goh, R Seishima, K Murakami, M Oshima, ... Nature 578 (7795), 437-443, 2020 | 106 | 2020 |
| A tumour-resident Lgr5+ stem-cell-like pool drives the establishment and progression of advanced gastric cancers A Fatehullah, Y Terakado, S Sagiraju, TL Tan, T Sheng, SH Tan, ... Nature Cell Biology 23 (12), 1299-1313, 2021 | 41 | 2021 |
| CRISPRi enables isoform-specific loss-of-function screens and identification of gastric cancer-specific isoform dependencies R Davies, L Liu, S Taotao, N Tuano, R Chaturvedi, KK Huang, C Itman, ... Genome biology 22, 1-19, 2021 | 15 | 2021 |
| Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer M Xing, WF Ooi, J Tan, A Qamra, PH Lee, Z Li, C Xu, N Padmanabhan, ... The Journal of clinical investigation 130 (6), 3005-3020, 2020 | 15 | 2020 |
| Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities SWT Ho, T Sheng, M Xing, WF Ooi, C Xu, R Sundar, KK Huang, Z Li, ... Gut 72 (2), 226-241, 2023 | 13 | 2023 |
| Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression KK Huang, H Ma, RHH Chong, T Uchihara, BSX Lian, F Zhu, T Sheng, ... Cancer cell 41 (12), 2019-2037. e8, 2023 | 11 | 2023 |
| Chromatin rewiring by mismatch repair protein MSH2 alters cell adhesion pathways and sensitivity to BET inhibition in gastric cancer AM Nargund, C Xu, A Mandoli, A Okabe, GB Chen, KK Huang, T Sheng, ... Cancer Research 82 (14), 2538-2551, 2022 | 8 | 2022 |
| Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer T Sheng, SWT Ho, WF Ooi, C Xu, M Xing, N Padmanabhan, KK Huang, ... Genome medicine 13, 1-25, 2021 | 8 | 2021 |
| DEF: an automated dead-end filling approach based on quasi-endosymbiosis L Liu, Z Zhang, T Sheng, M Chen Bioinformatics 33 (3), 405-413, 2017 | 7 | 2017 |
| Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities C Xu, KK Huang, JH Law, JS Chua, T Sheng, NM Flores, MP Pizzi, ... Gut 72 (9), 1651-1663, 2023 | 6 | 2023 |
| DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial R Sundar, A Ng, H Zouridis, N Padmanabhan, T Sheng, S Zhang, MH Lee, ... European Journal of Cancer 123, 48-57, 2019 | 5 | 2019 |
| DNA methylation signature predictive of benefit from neoadjuvant chemotherapy in esophageal adenocarcinoma: Results from the MRC OEO2 phase III trial. R Sundar, A Ng, H Zouridis, T Sheng, S Zhang, MH Lee, N Padmanabhan, ... Journal of Clinical Oncology 37 (4_suppl), 43-43, 2019 | 2 | 2019 |
| Author Correction: CRISPRi enables isoform-specific loss-of-function screens and identification of gastric cancer-specific isoform dependencies R Davies, L Liu, S Taotao, N Tuano, R Chaturvedi, KK Huang, C Itman, ... Genome Biology 22, 1-2, 2021 | 1 | 2021 |
| Abstract P28: Comprehensive Molecular Phenotyping of ARID1A-deficient Gastric Cancer Reveals Pervasive Epigenomic Reprogramming and Therapeutic … C Xu, KK Huang, JH Law, JS Chua, T Sheng, NM Flores, MP Pizzi, ... Cancer Research 84 (8_Supplement), P28-P28, 2024 | | 2024 |
| Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases JJ Zhao, JCA Ong, S Srivastava, DKA Chia, H Ma, KK Huang, T Sheng, ... bioRxiv, 2024.03. 21.585686, 2024 | | 2024 |
| Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer AM Nargund, C Xu, A Mandoli, A Okabe, GB Chen, KK Huang, T Sheng, ... Cancer Research 83 (5), 804-804, 2023 | | 2023 |
